Dabigatran-induced acute hepatitis

Clinical and Applied Thrombosis/Hemostasis

Volumn 18, Issue 5, 2012, Pages 549-550

  Rochwerg, Bram ^a   Xenodemetropoulos, Ted ^a   Crowther, Mark ^a   Spyropoulos, Alex ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DABIGATRAN; WARFARIN; XIMELAGATRAN;

ACUTE HEPATITIS; AGED; ANOREXIA; ANTICOAGULANT THERAPY; BLOOD CHEMISTRY; CASE REPORT; CEREBROVASCULAR ACCIDENT; CHRONIC LIVER DISEASE; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ECHOGRAPHY; FATIGUE; HEART ATRIUM FIBRILLATION; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; JAUNDICE; LABORATORY TEST; LETTER; LIVER BIOPSY; LIVER TOXICITY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SYMPTOM; TOXIC HEPATITIS;

AGED; ANTITHROMBINS; ATRIAL FIBRILLATION; BENZIMIDAZOLES; BETA-ALANINE; CHRONIC DISEASE; DRUG-INDUCED LIVER INJURY; HUMANS; MALE;

EID: 84871729383     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029611435840     Document Type: Letter

References (6)

1. Halperin JL. Ximelagatran vs warfarin for stroke prevention in patients with non-valvular atrial fibrillation. JAMA. 2005 ; 293 (6). 690-698
2. WoodS. FDA opts not to approve Ximelagatran. Heartwire News [internet]. 2004 Oct 8. Available from: http://www.theheart.org/article/648941.do
3. Connelly S, Ezekowitz M, Yusuf S, et al. Dabigatran vs warfarin in patients with atrial fibrillation. New Eng J Med. 2009 ; 361 (12). 1139-1151
4. Eriksson B, Dahl O, Buller R, et al. A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. J Throm Haem. 2004 ; 3 (1). 103-111
5. MedEffect Canada adverse reaction database [internet]. Health Canada. Available from: http://www.hc-sc.gc.ca/dhp-mps/medeff/databasdon/index-eng.php
6. Reuben A. Hy's Law. Hepatology. 2004 ; 39 (2). 574-578